MiR-22, the levels of which are decreased in diabetic myocardium in T1DM STZ-induced diabetes model, was found to target SIRT1 leading to the upregulation of SIRT1 protein expression [94]. The gene discussed is SIRT1; the disease is diabetes mellitus.